Zobrazeno 1 - 10
of 39
pro vyhledávání: '"AKIFUMI KUWANO"'
Autor:
Akifumi Kuwano, Masayoshi Yada, Kazuki Kurosaka, Kosuke Tanaka, Akihide Masumoto, Kenta Motomura
Publikováno v:
JGH Open, Vol 7, Iss 2, Pp 98-104 (2023)
Abstract Background and Aim Direct‐acting antivirals (DAAs) have recently been developed to treat hepatitis C virus (HCV) infection. Additionally, interferon‐free DAA treatment has improved liver function and reduced the risk of hepatocellular ca
Externí odkaz:
https://doaj.org/article/04fbf6e554fa41ce866926d5ac88c275
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 5, Pp 621-622 (2023)
Externí odkaz:
https://doaj.org/article/40233e99e7eb49b89d6a306a4892ff3f
Autor:
Akifumi Kuwano, Masatake Tanaka, Hideo Suzuki, Miho Kurokawa, Koji Imoto, Shigeki Tashiro, Takeshi Goya, Motoyuki Kohjima, Masaki Kato, Yoshihiro Ogawa
Publikováno v:
Biochemistry and Biophysics Reports, Vol 27, Iss , Pp 101068- (2021)
Liver fibrosis induces intrahepatic microcirculation disorder and hypoxic stress. Hypoxic stress has the potential for an increase in the possibility of more liver fibrosis and carcinogenesis. Liver biopsy is a standard method that evaluates of intra
Externí odkaz:
https://doaj.org/article/c6a715874fe445d98fd0fcfa9ffa931d
Autor:
Hideo Suzuki, Motoyuki Kohjima, Masatake Tanaka, Takeshi Goya, Shinji Itoh, Tomoharu Yoshizumi, Masaki Mori, Mariko Tsuda, Motoi Takahashi, Miho Kurokawa, Koji Imoto, Shigeki Tashiro, Akifumi Kuwano, Masaki Kato, Seiji Okada, Makoto Nakamuta, Yoshihiro Ogawa
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Objective. Metabolic alteration is widely considered as one of the hallmarks of cancer. Hepatocellular carcinoma (HCC) presents a unique pathological feature in which lipid accumulation is common in well-differentiated HCC and rare in poorly differen
Externí odkaz:
https://doaj.org/article/0dd370627150485da6c33cc6ea90e634
Autor:
Koji Imoto, Motoyuki Kohjima, Tomonobu Hioki, Tomoyuki Kurashige, Miho Kurokawa, Shigeki Tashiro, Hideo Suzuki, Akifumi Kuwano, Masatake Tanaka, Seiji Okada, Masaki Kato, Yoshihiro Ogawa
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2019 (2019)
Aim. Immune checkpoint inhibitors (ICIs) have improved the survival rate of patients carrying various malignant neoplasms. Despite their efficacy, ICIs occasionally induce liver injury as an immune-related adverse event (irAE). This study aimed to re
Externí odkaz:
https://doaj.org/article/f2c16e45c8eb484aa910ec47779173e3
Autor:
AKIFUMI KUWANO1, SHIGEHIRO NAGASAWA1, YUTA KOGA1, KOSUKE TANAKA1 ktanakah8@aih-net.com, MASAYOSHI YADA1, AKIHIDE MASUMOTO1, KENTA MOTOMURA1
Publikováno v:
Experimental & Therapeutic Medicine. Sep2024, Vol. 28 Issue 3, p1-7. 7p.
Autor:
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
In Vivo; Jul/Aug2024, Vol. 38 Issue 4, p1854-1858, 5p
Autor:
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Mar/Apr2024, Vol. 4 Issue 2, p111-116, 6p
Autor:
Akifumi Kuwano, Masayoshi Yada, Kazuki Kurosaka, Kosuke Tanaka, Akihide Masumoto, Kenta Motomura
Publikováno v:
JGH Open. 7:98-104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b90c5b1cd7a294a48ffce14b3d1992b
https://doi.org/10.1002/jgh3.12855
https://doi.org/10.1002/jgh3.12855
Autor:
AKIFUMI KUWANO1, KOSUKE TANAKA1 ktanakah8@aihnet.com, MASAYOSHI YADA1, SHIGEHIRO NAGASAWA1, YUSUKE MORITA1, AKIHIDE MASUMOTO1, KENTA MOTOMURA1
Publikováno v:
Molecular & Clinical Oncology. Feb2022, Vol. 16 Issue 2, p1-10. 10p.